These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33840338)

  • 21. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism.
    Ghazvinian R; Gottsäter A; Elf JL
    J Thromb Thrombolysis; 2018 Feb; 45(2):319-324. PubMed ID: 29305675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism. Outpatient versus inpatient management.
    Al-Hameed FM; Al-Dorzi HM; Al-Momen AM; Algahtani FH; Al-Zahrani HA; Al-Saleh KA; Al-Sheef MA; Owaidah TM; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schunemann H; Akl EA
    Saudi Med J; 2015 Aug; 36(8):1004-10. PubMed ID: 26219456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing the hospital burden associated with the treatment of pulmonary embolism.
    Peacock WF; Singer AJ
    J Thromb Haemost; 2019 May; 17(5):720-736. PubMed ID: 30851227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Operative spinal trauma: Thromboprophylaxis with low molecular weight heparin or a direct oral anticoagulant.
    Hamidi M; Zeeshan M; Kulvatunyou N; Mitra HS; Hanna K; Tang A; Northcutt A; O'Keeffe T; Joseph B
    J Thromb Haemost; 2019 Jun; 17(6):925-933. PubMed ID: 30924300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study protocol for a multicentre implementation trial of monotherapy anticoagulation to expedite home treatment of patients diagnosed with venous thromboembolism in the emergency department.
    Kline J; Adler D; Alanis N; Bledsoe J; Courtney D; D'Etienne J; B Diercks D; Garrett J; Jones AE; MacKenzie D; Madsen T; Matuskowitz A; Mumma B; Nordenholz K; Pagenhardt J; Runyon M; Stubblefield W; Willoughby C
    BMJ Open; 2020 Oct; 10(10):e038078. PubMed ID: 33004396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism management: where do novel anticoagulants fit?
    Spyropoulos AC; Turpie AG
    Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study.
    Zondag W; Mos IC; Creemers-Schild D; Hoogerbrugge AD; Dekkers OM; Dolsma J; Eijsvogel M; Faber LM; Hofstee HM; Hovens MM; Jonkers GJ; van Kralingen KW; Kruip MJ; Vlasveld T; de Vreede MJ; Huisman MV;
    J Thromb Haemost; 2011 Aug; 9(8):1500-7. PubMed ID: 21645235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
    Maughan BC; Frueh L; McDonagh MS; Casciere B; Kline JA
    Acad Emerg Med; 2021 Feb; 28(2):226-239. PubMed ID: 32779290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
    Tagalakis V; Patenaude V; Kahn SR; Suissa S
    Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic Emergencies: Too Much Clotting-Venous Thromboembolism in Malignancy.
    Long B; Koyfman A
    J Emerg Med; 2019 Dec; 57(6):825-835. PubMed ID: 31627886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating patients with cancer and acute venous thromboembolism.
    Donadini MP; Squizzato A; Ageno W
    Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
    Pelletier R
    J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.